Chad P. Bown (PIIE) and Chris Rogers (S&P Global Market Intelligence Panjiva)
Contrary to assertions, notably by companies in India, there was never a US embargo on materials and equipment needed to produce COVID-19 vaccines. Input shortages are the result of rapidly scaling up vaccine production and surging demand. A new global vaccine supply chain policy is necessary to avert future shortfalls and help allocate supplies.
The Peterson Institute for International Economics building is closed to staff and visitors until further notice. PIIE personnel are working remotely, with access to telephone messages.